Cravatex Ltd (CRAVATEX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Cravatex Ltd on NSE and BSE, with an AI summary of each filing.
Outcome of the Board Meeting held on 3rd November, 2026 is attached.
Outcome · 03 Nov 2026, 10:24 pm
Unaudited Financial Results for the quarter and half year ended 30th September, 2026 are attached.
Financial Result · 03 Nov 2026, 10:21 pm
Cravatex Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 5,346 (+3.9% YoY | +65.9% QoQ) ■ EBITDA: 306 (+10.9% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 5.7 (+36 bps YoY | Loss to Profit QoQ) ■ PAT: 462 (-11.4% YoY | +954.9% QoQ) ■ EPS (INR): 17.9 (-11.4% YoY | +951.8% QoQ)
Cravatex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the unaudited financial results (standalone ....
Intimation · 03 Nov 2026, 5:30 am
Cravatex Schedules Board Meeting to Approve Q2 and H1 Financial Results Cravatex Limited has informed the exchange that a meeting of its Board of Directors is scheduled for 3rd Nov'26. The board will, inter alia, consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26, in compliance with Regulation 29(1) of SEBI Listing Regulations.
Outcome of Board Meeting held on 12th August, 2026 is attached.
Outcome · 12 Aug 2026, 10:15 pm
Cravatex Q1'27: Strong Revenue Growth but Sharp Drop in Consolidated Profit Cravatex reported strong YoY revenue growth for Q1 ending 30th Jun'26. Consolidated revenue grew 39.3% YoY to ₹3,662.63 lacs, but PAT fell to ₹43.81 lacs from a loss of ₹136.77 lacs last year. The profit decline was primarily driven by a 41.3% YoY increase in total expenses. On a standalone basis, revenue rose slightly by 0.2% YoY to ₹144.49 lacs, while PAT decreased 7.1% YoY to ₹41.08 lacs. Consolidated EPS stood at ₹1.70, compared to a negative EPS of ₹5.29 YoY.
Unaudited Financial Results for the quarter ended 30th June, 2026 are attached.
Financial Result · 12 Aug 2026, 10:11 pm
Cravatex Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 3,222 (+39.3% YoY | -18.4% QoQ) ■ EBITDA: -327 (+46.4% YoY | -451.6% QoQ) ■ EBITDA Margin (%): -10.2 (+1623 bps YoY | -865 bps QoQ) ■ PAT: 43.8 (Loss to Profit YoY | -72.6% QoQ) ■ EPS (INR): 1.70 (Loss to Profit YoY | -72.5% QoQ)
Cravatex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the unaudited financial results (standalone ....
Intimation · 12 Aug 2026, 5:30 am
Cravatex Schedules Board Meeting for Q1 FY27 Results Cravatex Limited (BSE: 509472) has scheduled a Board of Directors meeting on 12 Aug'26. The agenda includes the consideration and approval of the company's unaudited standalone and consolidated financial results for the first quarter ending 30 Jun'26.
Voting Results alongwith Scrutinizer''s Report for 74th Annual General Meeting of Cravatex Limited held on 31st July, 2026 at 3.30 p.m. IST is attached.
Annual General Meeting · 03 Aug 2026, 7:56 pm
Summary of Proceedings of 74th Annual General Meeting of Cravatex Limited held on 31st July, 2026 at 3.30 p.m. IST is attached.
Annual General Meeting · 31 Jul 2026, 9:55 pm
Letter for Weblink of Annual Report 2025-26 sent to those shareholders who have not registered their email address is attached.
Annual Report · 01 Jul 2026, 9:00 pm
Notice alongwith Annual Report 2025-26 for 74th Annual General Meeting of Cravatex Limited scheduled to be held on Friday, 31st July, 2026 at 3.30 p.m. IST through VC / OAVM is attached.
Annual General Meeting · 01 Jul 2026, 8:45 pm
Notice alongwith Annual Report 2025-26 for 74th Annual General Meeting of Cravatex Limited scheduled to be held on Friday, 31st July, 2026 at 3.30 p.m. IST through VC / OAVM is attached.
Others (Uncategorized) · 01 Jul 2026, 8:37 pm
Intimation of record date for AGM and entitlement to final dividend for the financial year ended 31st March, 2026 is attached.
Dividend · 19 May 2026, 4:27 pm
Cravatex Sets Record Date for FY26 Final Dividend Cravatex Limited has announced a record date of 24th Jul'26 for its 74th Annual General Meeting and to determine shareholder eligibility for the final dividend for the financial year ending 31st Mar'26. The dividend payment is contingent upon shareholder approval at the upcoming AGM. This action follows the company's board meeting outcome intimated on 15th May'26.
Intimation for Appointment of Secretarial Auditor is attached.
Change in Auditor · 15 May 2026, 10:58 pm
Cravatex Board Approves FY26 Results and Recommends Rs.13 Final Dividend Cravatex's board approved audited financial results for the year ended 31st Mar'26, accompanied by an unmodified auditors' report. A final dividend of Rs.13 per share (130% of face value) was recommended, subject to shareholder approval at the upcoming AGM. The company has scheduled its 74th AGM for 31st Jul'26, with the book closure for dividend entitlement set from 25th Jul'26 to 31st Jul'26. Additionally, the board appointed M/s Hemanshu Kapadia & Associates as Secretarial Auditors for FY26-27.
Intimation for date of 74th Annual General Meeting is attached.
Annual General Meeting · 15 May 2026, 10:53 pm
Cravatex Board Recommends Rs. 13/share Final Dividend for FY26 Cravatex's board approved audited financial results for the year ended 31st Mar'26. A final dividend of Rs. 13 per share (130% of face value) has been recommended, subject to shareholder approval. The 74th Annual General Meeting (AGM) is scheduled for 31st Jul'26. The record date for the dividend is set from 25th Jul'26 to 31st Jul'26. The board also appointed M/s Hemanshu Kapadia & Associates as Secretarial Auditors for FY27.
Recommendation for Final Dividend 2025-26 is attached.
Dividend · 15 May 2026, 10:48 pm
Cravatex Board Recommends Rs. 13/share Dividend for FY26 The Board of Cravatex, at its meeting on 15th May'26, approved audited financial results for the year ended 31st Mar'26. It recommended a final dividend of Rs. 13 per share (130%) on Rs. 10 face value shares for FY26, subject to shareholder approval. The company scheduled its 74th AGM for 31st Jul'26. The record date for dividend entitlement is set for 25th Jul'26 to 31st Jul'26 (inclusive). The Board also appointed M/s Hemanshu Kapadia & Associates as Secretarial Auditors for FY27.
Outcome of Board Meeting held on 15th May, 2026 is attached.
Outcome · 15 May 2026, 10:42 pm
CRAVATEX LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 3951 (-34.7% YoY | +7.4% QoQ) ■ EBITDA: -59.3 (Profit to Loss YoY | +75.7% QoQ) ■ EBITDA Margin (%): -1.5 (Profit to Loss YoY | +513 bps QoQ) ■ PAT: 160 (+10.9% YoY | +18.8% QoQ) ■ EPS (INR): 6.19 (+10.7% YoY | +18.8% QoQ)
Audited Financial Results for the quarter and year ended 31st March, 2026 are attached.
Financial Result · 15 May 2026, 10:38 pm
CRAVATEX LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 3951 (-34.7% YoY | +7.4% QoQ) ■ EBITDA: -59.3 (Profit to Loss YoY | +75.7% QoQ) ■ EBITDA Margin (%): -1.5 (Profit to Loss YoY | +513 bps QoQ) ■ PAT: 160 (+10.9% YoY | +18.8% QoQ) ■ EPS (INR): 6.19 (+10.7% YoY | +18.8% QoQ)
Cravatex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the audited financial results (standalone ....
Intimation · 15 May 2026, 5:30 am
Cravatex Board Meeting on 15 May'26 for FY26 Results & Dividend Cravatex Ltd. will hold a Board Meeting on 15 May'26 to consider and approve its audited standalone and consolidated financial results for the quarter and financial year ended 31 Mar'26. The board will also consider a recommendation for a final dividend for FY26.
Intimation for re-appointment of Mr. Divakar G. Kamath as the Executive Director and Chief Financial Officer of the Company for a further period of 3 years from 1st April, 2026 to 31st ....
Change in Management · 30 Mar 2026, 6:19 pm
Cravatex Re-appoints Divakar Kamath as ED & CFO for Three Years Cravatex Limited's board has re-appointed Mr. Divakar G. Kamath as Executive Director and Chief Financial Officer for a three-year term, effective from 01st Apr'26 to 31st Mar'29. The appointment, not liable to retire by rotation, is subject to member approval. Mr. Kamath, who joined as CFO in 2012, has over 32 years of banking experience, including a prior role as SVP at Axis Bank. The re-appointment ensures leadership continuity in the company's key financial and executive functions.
Unaudited Financial Results for the quarter and nine months ended 31st December, 2025 are attached.
Financial Result · 13 Feb 2026, 12:27 am
CRAVATEX LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lacs) ■ Revenue: 3679 (+13.4% YoY | -28.5% QoQ) ■ EBITDA: -244 (-30.3% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -6.6 (-86 bps YoY | Profit to Loss QoQ) ■ PAT: 135 (+438.2% YoY | -74.2% QoQ) ■ EPS (INR): 5.21 (+437.1% YoY | -74.2% QoQ)
Cravatex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the unaudited financial results (standalone ....
Intimation · 12 Feb 2026, 5:30 am
Cravatex Board Meeting on 12th Feb'26 for Q3 FY26 Results Cravatex Limited (BSE: 509472) has scheduled a Board of Directors meeting for 12th Feb'26. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st Dec'25. This announcement is a key event for investors tracking the company's Q3 FY26 performance.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Batra
Acquisition/ Disposal of Shares · 19 Nov 2025, 5:56 pm
Unaudited Financial Results for the quarter ended 30th September, 2025 are attached.
Financial Result · 14 Nov 2025, 10:10 pm
Cravatex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the unaudited financial results for ....
Intimation · 14 Nov 2025, 5:30 am
Intimation for change in email id of the share transfer agents of the Company is attached.
Others (Uncategorized) · 30 Sept 2025, 5:04 pm